APC and neoplasm: The analysis of various mutant combinations allowed the determination that the initiating APC and KRAS mutations act as the drivers of proliferation and tumor growth, while inactivating mutations in SMAD4 block differentiation during tumor growth and being required for metastatic potential [295].